---
identifier: "/us/cfr/t21/s343.50-343.60"
source: "ecfr"
legal_status: "authoritative_unofficial"
title: "21 CFR § 343.50-343.60 - §§ 343.50-343.60 [Reserved]"
title_number: 21
title_name: "Food and Drugs"
section_number: "343.50-343.60"
section_name: "§§ 343.50-343.60 [Reserved]"
chapter_name: "FOOD AND DRUG ADMINISTRATION, DEPARTMENT OF HEALTH AND HUMAN SERVICES"
subchapter_number: "D"
subchapter_name: "DRUGS FOR HUMAN USE"
part_number: "343"
part_name: "INTERNAL ANALGESIC, ANTIPYRETIC, AND ANTIRHEUMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE"
positive_law: false
currency: "2026-04-05"
last_updated: "2026-04-05"
format_version: "1.1.0"
generator: "[email protected]"
authority: "21 U.S.C. 321, 351, 352, 353, 355, 360, 371."
regulatory_source: "63 FR 56814, Oct. 23, 1998, unless otherwise noted."
cfr_part: "343"
---
- Identifier
- /us/cfr/t21/s343.50-343.60
- Currency
- 2026-04-05
- Positive Law
- No
- Updated
- 2026-04-05
- Chapter
- Food and Drug Administration, Department of Health and Human Services
- Authority
- 21 U.S.C. 321, 351, 352, 353, 355, 360, 371.